Merck : MRK

All Merck Articles

1067 Articles

Jon C. Ogg | Jan 3, 2018 at 8:35 AM EST

2018 Bull/Bear Outlook: How All 30 DJIA Stocks Will Take the Market to 26,400 or Higher

Here is a consensus forecast of each of the 30 Dow Jones Industrial stocks, including a forward 12-month consensus analyst…

Paul Ausick | Dec 30, 2017 at 9:30 AM EST

The Worst 5 DJIA Stocks of 2017

In a year that saw the Dow add more than 24%, 5 stocks posted share price declines ranging from 1%…

Paul Ausick | Dec 28, 2017 at 4:01 PM EST

UnitedHealth, American Express Prop Up DJIA on Thursday

UnitedHealth, American Express, Merck, and IBM led the DJIA to a positive finish on Thursday.

Chris Lange | Dec 28, 2017 at 10:25 AM EST

More and More Short Sellers Raising the Stakes in Major Pharma

The December 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Dec 26, 2017 at 11:15 AM EST

Meet the Preliminary Dogs of the Dow for 2018

One strategy that has been popular each year as investors rebalance and make changes is the so-called Dogs of the…

Jon C. Ogg | Dec 16, 2017 at 9:45 AM EST

20 Fresh Stock Buybacks Could Send $100 Billion Back to Shareholders

With the passage of tax reform looking almost certain, and with companies continuing to prove that all-time highs in the…

Paul Ausick | Dec 14, 2017 at 4:01 PM EST

Caterpillar, UnitedHealth Lead DJIA Slide Thursday

Caterpillar, UnitedHealth, Merck, and Verizon were among the largest losers among DJIA stocks on Thursday.

Chris Lange | Dec 12, 2017 at 10:40 AM EST

Short Sellers Can’t Make Up Their Minds on Major Pharma

The November 30 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Paul Ausick | Dec 11, 2017 at 4:01 PM EST

Disney, Apple Pace Dow to Monday Gain

Apple, Disney, Merck, and Pfizer were the leading gainers among the Dow 30 stocks on Monday. Bitcoin settled up 23%…

Lee Jackson | Dec 7, 2017 at 8:55 AM EST

Merrill Lynch Says 5 Dow Jones Laggards Could Be 2018 Winners

The question for investors is pretty simple: 2017 was great, but what do they do for an encore in 2018?

Jon C. Ogg | Dec 7, 2017 at 7:35 AM EST

2018 Outlook: How Exxon, GE, IBM, Merck and Disney Could Be the Top Dow Stocks

Some down and out stocks don't always stay down, and sometimes great turnarounds and recoveries can create huge victories for opportunistic…

Paul Ausick | Dec 6, 2017 at 4:01 PM EST

Microsoft, Merck Lead DJIA to Close Flat Wednesday

Microsoft and Vise were Wednesday's big DJIA gainers while Merck and Disney dipped the most.

Jon C. Ogg | Dec 6, 2017 at 10:05 AM EST

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately,…

Lee Jackson | Nov 30, 2017 at 10:00 AM EST

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

One area to look at in this overbought and pricey market is pharmaceuticals. These five now are considered to be…

Paul Ausick | Nov 20, 2017 at 4:04 PM EST

Merck, Cardinal Health Drop into Monday’s 52-Week Low Club

Merck, Omega Health, Cardinal Health, and Curis all posted new 52-week lows Monday.

1 … 24 25 26 27 28 … 72

Merck : MRK

All Merck Articles

2018 Bull/Bear Outlook: How All 30 DJIA Stocks Will Take the Market to 26,400 or Higher

The Worst 5 DJIA Stocks of 2017

UnitedHealth, American Express Prop Up DJIA on Thursday

More and More Short Sellers Raising the Stakes in Major Pharma

Meet the Preliminary Dogs of the Dow for 2018

20 Fresh Stock Buybacks Could Send $100 Billion Back to Shareholders

Caterpillar, UnitedHealth Lead DJIA Slide Thursday

Short Sellers Can’t Make Up Their Minds on Major Pharma

Disney, Apple Pace Dow to Monday Gain

Merrill Lynch Says 5 Dow Jones Laggards Could Be 2018 Winners

2018 Outlook: How Exxon, GE, IBM, Merck and Disney Could Be the Top Dow Stocks

Microsoft, Merck Lead DJIA to Close Flat Wednesday

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

Merck, Cardinal Health Drop into Monday’s 52-Week Low Club

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

This High-Yield Emerging Funds ETF Offers International Diversification

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

Merck : MRK

All Merck Articles

2018 Bull/Bear Outlook: How All 30 DJIA Stocks Will Take the Market to 26,400 or Higher

The Worst 5 DJIA Stocks of 2017

UnitedHealth, American Express Prop Up DJIA on Thursday

More and More Short Sellers Raising the Stakes in Major Pharma

Meet the Preliminary Dogs of the Dow for 2018

20 Fresh Stock Buybacks Could Send $100 Billion Back to Shareholders

Caterpillar, UnitedHealth Lead DJIA Slide Thursday

Short Sellers Can’t Make Up Their Minds on Major Pharma

Disney, Apple Pace Dow to Monday Gain

Merrill Lynch Says 5 Dow Jones Laggards Could Be 2018 Winners

2018 Outlook: How Exxon, GE, IBM, Merck and Disney Could Be the Top Dow Stocks

Microsoft, Merck Lead DJIA to Close Flat Wednesday

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

Merck, Cardinal Health Drop into Monday’s 52-Week Low Club

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

This High-Yield Emerging Funds ETF Offers International Diversification

Featured Reads

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month